The inflammation-based Glasgow Prognostic Score (GPS) is a scoring system combining elevated C-reactive protein (CRP) serum levels and hypoalbuminemia, factors for inflammation and hypermetabolism, used to stratify patients into risk groups for predicting clinical outcome. The gene discussed is CRP; the disease is Hypoalbuminemia.